Search | Clinical Trials Finder

Conditions: Autonomic Neuropathy, Male Hypogonadism
Interventions: Not listed
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 40 Years to 80 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System, Wounds and Injury, Central Nervous System Diseases, Spinal Cord Diseases, Gonadal Disorders, Endocrine System Diseases, Hypogonadism, Genital Diseases, Male, Spinal Cord Trauma, Injuries, Spinal Cord, Walking, Difficulty, Gait Disorders, Neurologic, Locomotion Disorder, Neurologic, Wounds and Injuries, Nervous System Diseases, Testosterone Deficiency, Androgen Deficiency, Hormone Deficiency
Interventions: Testosterone Enanthate, Locomotor Training; Drug · Behavioral
Lead sponsor: North Florida Foundation for Research and Education; Other
Eligibility: 18 Years and older · Male only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Hypogonadism
Interventions: AndroGel (Transdermal Testosterone Gel); Drug
Lead sponsor: Lamm, Steven, M.D.; Individual
Eligibility: 21 Years to 59 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Sclerosis, Erectile Dysfunction, Testosterone Deficiency
Interventions: XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector; Drug
Lead sponsor: Tulane University; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Arthroplasty, Replacement, Hip
Interventions: Testosterone Therapy, No Testosterone Therapy; Drug · Other
Lead sponsor: American Hip Institute; Other
Eligibility: 50 Years and older · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Des Plaines, Illinois

Conditions: Testosterone Deficiency, Hypogonadism, Male
Interventions: Testosterone; Drug
Lead sponsor: Men's Health Boston; Other
Eligibility: 18 Years to 90 Years · Male only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • Honolulu, Hawaii + 3 more

Conditions: Hip Fracture, Testosterone Deficiency, Muscle Weakness
Interventions: Testosterone gel; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 65 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypogonadism, Hypogonadism, Male
Interventions: Nanomilled testosterone, commercially available dutasteride, Nanomilled dutasteride; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2006
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Hysterectomy, Ovariectomy, Menopause, Testosterone Deficiency
Interventions: Testosterone; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 21 Years to 60 Years · Female only
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypogonadism, Male, Cancer, Fatigue
Interventions: testosterone 1.62% gel, placebo gel; Drug · Other
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 55 Years and older · Male only
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Augusta, Georgia • Boston, Massachusetts • Seattle, Washington

Conditions: HIV Infections, Cachexia
Interventions: testosterone; Drug
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2001
U.S. locations: 3
States / cities: Los Angeles, California • Torrance, California • St Louis, Missouri

Conditions: Testosterone Deficiency
Interventions: Testosterone Therapy; Drug
Lead sponsor: Men's Health Boston; Other
Eligibility: 20 Years to 90 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Testosterone Deficiency
Interventions: Not listed
Lead sponsor: Men's Health Boston; Other
Eligibility: 18 Years to 46 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Panhypopituitarism
Interventions: Not listed
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 18 Years to 55 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Panhypopituitarism
Interventions: Transdermal Testosterone gel; Drug
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Aqueous Tear Deficiency, Meibomian Gland Dysfunction of Bilateral Eyes (Disorder)
Interventions: Testosterone gel 4.5%, Vehicle gel; Drug
Lead sponsor: Southern California College of Optometry at Marshall B. Ketchum University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Fullerton, California

Conditions: Spinal Cord Injuries, Endothelial Dysfunction, Testosterone Deficiency
Interventions: Intra-arterial Infusion of Vasoactive Agents, Intra-arterial Vitamin C Infusion, Blood Sampling; Diagnostic Test
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years to 89 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Hypogonadism, Testosterone Deficiency
Interventions: ABT-SLV176; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 80 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 42
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 37 more

Conditions: Testosterone Deficiency
Interventions: Clomiphene Citrate 25mg, Clomiphene Citrate 50mg; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 21 Years to 45 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypogonadism, Male
Interventions: Testosterone enanthate; Combination Product
Lead sponsor: Halozyme Therapeutics; Industry
Eligibility: 12 Years to 17 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 20
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 17 more

Conditions: Aging, Testosterone Deficiency
Interventions: AlphaFen fenugreek 400 mg, AlphaFen fenugreek 500 mg, Placebo; Dietary Supplement · Other
Lead sponsor: Jacksonville University; Other
Eligibility: 21 Years to 45 Years · Male only
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Primary Hypogonadism, Hypogonadotropic Hypogonadism
Interventions: Testosterone Topical Gel, 1.62% Metered Pump, AndroGel (testosterone gel) 1.62% Metered-Dose Pump; Drug
Lead sponsor: Amneal Pharmaceuticals, LLC; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Miami Gardens, Florida

Conditions: Hypogonadism, Benign Prostatic Hyperplasia
Interventions: Dutasteride, Testosterone gel, Placebo dutasteride; Drug
Lead sponsor: University of Washington; Other
Eligibility: 50 Years and older · Male only
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Seattle, Washington

Search by objective public record fields.

Autonomic Manifestations of Testosterone Deficiency in Men

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled Trial

Subcutaneous vs. Intramuscular Testosterone

Use of a Test That Evaluates How the Body Handles Insulin and Glucose

Testosterone Therapy After Hip Fracture in Elderly Women

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

TDSM- Testosterone Dose Response in Surgically Menopausal Women

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

Metabolomics During Testosterone Therapy

Diurnal Testosterone Concentration

Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism

Testosterone Gel Applied to Women With Pituitary Gland Problems

Eyelid Androgen Treatment in Dry Eye

Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene Citrate

52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

The Efficacy of Fenugreek Supplementation on Men's Health

Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

TRADE-Testosterone Replacement and Dutasteride Effectiveness